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Clinical Infectious Diseases
SUPPLEMENT ARTICLE
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Background. Blood culture is the current standard for diagnosing bacteremic illnesses, yet it is not clear how physicians in many
low- and middle-income countries utilize blood culture for diagnostic purposes and to inform treatment decisions.
Methods. We screened suspected enteric fever cases from 6 hospitals in Bangladesh, Nepal, and Pakistan, and enrolled patients
if blood culture was prescribed by the treating physician. We used generalized additive regression models to analyze the probability
of receiving blood culture by age, and linear regression models to analyze changes by month to the proportion of febrile cases prescribed a blood culture compared with the burden of febrile illness, stratified by hospital. We used logistic regression to analyze predictors for receiving antibiotics empirically. We descriptively reviewed changes in antibiotic therapy by susceptibility patterns and
coverage, stratified by country.
Results. We screened 30 809 outpatients resulting in 1819 enteric fever cases; 1935 additional cases were enrolled from other
hospital locations. Younger outpatients were less likely to receive a blood culture. The association between the number of febrile
outpatients and the proportion prescribed blood culture varied by hospital. Antibiotics prescribed empirically were associated with
severity and provisional diagnoses, but 31% (1147/3754) of enteric fever cases were not covered by initial therapy; this was highest in
Pakistan (50%) as many isolates were resistant to cephalosporins, which were commonly prescribed empirically.
Conclusions. Understanding hospital-level communication between laboratories and physicians may improve patient care and
timeliness of appropriate antibiotics, which is important considering the rise of antimicrobial resistance.
Keywords. blood culture; fever; typhoid; South Asia; antimicrobial resistance.
Blood culture is the currently accepted standard for diagnosing
suspected cases of bacteremia. In most high-income countries,
blood cultures are routinely drawn for febrile patients when
bacteremia is suspected. However, in resource-constrained settings, clinicians may choose to treat patients with antibiotics
empirically, in part due to limited or absent laboratory capacity
[1, 2]. In the current era of increasing antimicrobial resistance
(AMR), particularly in South Asia [3, 4], blood cultures are an
increasingly important tool to guide appropriate treatment and
promote antimicrobial stewardship [5].
With a global action plan set forth by the World Health
Organization to combat AMR [6], and an awareness of how
AMR affects achieving Sustainable Development Goals
[7], a better understanding of the interaction between
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clinician decision-making, blood culture use, and prescribed
antimicrobials can help guide interventions to address AMR in
South Asia. Antimicrobial susceptibility results from blood cultures can help drive clinical decisions, including choosing an
appropriate antibiotic if one is required [2]. However, prior research demonstrates underutilization of blood cultures among
febrile patients in low- and middle-income countries (LMICs)
[8], and among patients ultimately found to be bacteremic [9].
In many LMICs, blood cultures might not be ordered for febrile cases when bacteremia is suspected for several reasons, including low sensitivity of the assay [10], high cost, and logistical
issues related to patient follow-up. Indeed, the long duration to
available results might dissuade clinicians from ordering cultures in settings such as outpatient departments, where many
patients might not return or be contactable for follow-up.
In addition to diagnostic testing, clinicians might not revise patient therapy in response to culture results [9], though
data on this topic are lacking in LMICs. In South Asia, the
burden of resistant organisms is high among gram-negative
organisms [11–13], including organisms that cause enteric
fever (Salmonella enteria serotypes Typhi and Paratyphi A)
[14, 15]. Of particular concern is the recent discovery and
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Utilization of Blood Culture in South Asia for the
Diagnosis and Treatment of Febrile Illness

spread of extensively drug-resistant (XDR) Salmonella Typhi,
a strain resistant to 5 different classes of antimicrobials [16,
17]. However, it is unclear if there have been meaningful
changes to clinician behavior in the context of an increasing
burden of antimicrobial resistance.
This study evaluated data from the Surveillance for Enteric
Fever in Asia Project (SEAP) that characterized the burden of
enteric fever in Bangladesh, Nepal, and Pakistan, including incidence rates, disease severity, and economic burden [18]. Here,
we report on the utilization of blood culture for clinical decision-making related to the diagnosis and treatment of potential
and confirmed bloodstream infections in these 3 South Asian
countries; this included assessing if demographic characteristics and febrile burden at the hospital predicted prescription of
blood cultures, predictors for receiving antibiotics before available blood culture results, and alterations to treatment regimen
based on blood culture results, as well as whether identification
of antibiotic resistant enteric fever resulted in alterations to
treatment regimen.

Shishu Sasthya Foundation Hospital (Bangladesh); Dhulikhel
Hospital and Kathmandu Medical College Hospital (Nepal)
(Table 1). More information on the sites is available in this
supplement [19–21].

For prospective surveillance, patients were screened for inclusion criteria based on the point of contact with SEAP staff. At
outpatient clinics and emergency departments, patients were
screened for ≥3 days of fever and residence within the hospital
catchment area, established by review of enteric fever patients’
addresses [22]. At inpatient wards, patients were screened for
clinical suspicion or laboratory-confirmed diagnosis of enteric fever, regardless of residential address and if not enrolled
at outpatient. Among those meeting SEAP inclusion criteria,
study staff determined if the attending physician prescribed a
blood culture. Per study protocol, only patients who had been
prescribed a blood culture, and/or who agreed to provide one,
were considered eligible for enrollment; patients received a
blood draw shortly after enrollment (if not already provided).
Patients were also enrolled retrospectively from laboratories if
Salmonella Typhi or Salmonella Paratyphi A infection was confirmed by blood culture, regardless of residential address, if the
patient was not already enrolled from outpatient or inpatient
wards.

METHODS
Study Design

SEAP was a prospective cohort study in hospitals in Bangladesh,
Nepal, and Pakistan [18]. Prospective recruitment occurred
from September 2016 to September 2019. This article presents
2 years of data from April 2017 through March 2019.

Data Collection

SEAP staff collected visit date, age, and sex information on all
patients meeting the inclusion criteria. If those patients were
prescribed a blood culture and gave consent for enrollment,
patients were interviewed about clinical information such as
symptoms, disease severity, and previous care-seeking behavior. Medical records were also reviewed to obtain data on
diagnoses, medication types and dates, laboratory analyses, and

Study Sites

Patients were recruited from inpatient, outpatient (including emergency departments), and hospital laboratories
in 6 hospitals: Aga Khan University Hospital and Kharadar
General Hospital (Pakistan); Dhaka Shishu Hospital and

Table 1. Site Characteristics and Overall Descriptive Statistics of Recruited Patients, Surveillance for Enteric Fever in Asia Project (SEAP)—Bangladesh,
Nepal and Pakistan, April 2017–March 2019
Bangladesh

Site location

Nepal

Dhaka Shishu
Hospital

Shishu Sasthya
Foundation Hospital

Dhulikhel
Hospital

Kathmandu Medical College
and Teaching Hospital

Dhaka`

Pakistan
Aga Khan
University
Hospital

Kharadar
General
Hospital

Dhaka

Dhulikhel

Kathmandu

Catchment area population 1 million

1 million

84 000

448 000

1.2 million

687 000

Population served

Urban

Urban

Peri-urban/Rural

Urban

Urban

Urban

Population recruited

Pediatric (≤15)

Pediatric (≤15)

Pediatric and adult Pediatric and adult

Pediatric and adult Pediatric
and adult

Level of adherence to recruitment protocol

Full

Partial

Full

Full

Partial

Partial

Patients recruited at outpatient

6949

12 187

1631

2020

4597

3425

Median age, (IQR)

3 (1.7–6)

3 (1.5–6)

20 (6–38)

20 (10–31)

20 (3–39)

4 (1.6–11)

Male sex, n (%)

3771 (54)

6741 (55)

902 (55)

1212 (60)

2414 (53)

1879 (55)

6114 (50)

1631 (100)

2020 (100)

1824 (40)

1852 (54)

Prescribed blood culture, 6949 (100)
n (%)

Karachi
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Inclusion Criteria

hospitalization. All data were entered into a custom, SQL-based
system using standardized tools.
Laboratory Analysis

Statistical Analysis

We separated our analyses based on adherence to the recruitment protocol (Figure 1). At Dhaka Shishu Hospital
(Bangladesh), all outpatients meeting the inclusion criteria
were prescribed a blood culture. At both hospitals in Nepal
(Dhulikhel Hospital and Kathmandu Medical College and
Teaching Hospital), the local Institutional Review Board permitted SEAP staff to ask patients who had not been prescribed
blood culture by physicians if they would consent to provide a
blood sample. Therefore, Dhaka Shishu Hospital (Bangladesh),
Dhulikhel Hospital (Nepal), and Kathmandu Medical College
and Teaching Hospital (Nepal) had full adherence to SEAP

Figure 1. Flow of data for analysis, Surveillance for Enteric Fever in Asia Project (SEAP)—Bangladesh, Nepal and Pakistan, April 2017–March 2019. Note: Full adherence = Attending physicians prescribed a blood culture for outpatients meeting the inclusion criteria (3 or more days of fever and residence within the hospital catchment
area); Partial adherence = Attending physicians only prescribed a blood culture based on clinical suspicion among those meeting the inclusion criteria.
S268 • cid 2020:71 (Suppl 3) • Hemlock et al
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All sites utilized BACTEC™ (Becton Dickinson, Baltimore,
MD) to assess for bacterial pathogens in blood collected from
participants. Susceptibility patterns of Salmonella Typhi and
Salmonella Paratyphi A isolates were assessed via disk diffusion
using Clinical & Laboratory Standards Institute guidelines [23].

recruitment protocol. At Shishu Sasthya Foundation Hospital
(Bangladesh), Aga Khan University Hospital (Pakistan), and
Kharadar General Hospital (Pakistan), physicians only prescribed blood culture based on clinical suspicion, therefore
did not fully adhere to the SEAP recruitment protocol (subsequently referred to as “partial adherence”).
Since all recruited patients at full adherence hospitals were
prescribed a blood culture, we utilized data from partial adherence hospitals for the analyses on prescription of blood
culture. To evaluate if the physician’s decision-making was
associated with age of the patient, we used generalized additive regression models stratified by hospital. We also assessed
whether physicians’ practice for prescribing blood cultures
was associated with current and/or prior febrile illness burden
in the outpatient wards. We used linear regression models to
estimate the association between the proportion of febrile
patients prescribed a blood culture in a calendar month and
the number of febrile cases recruited at outpatient wards in
the same month. We then created lagged febrile case burden
variables using the number of febrile cases in the previous
1–5 months and assessed in 5 additional models, stratified by
hospital (18 total models).

Ethical Considerations

Study protocols were reviewed by Institutional Review Boards in
the United States (Centers for Disease Control and Prevention),
Bangladesh (Bangladesh Institute of Child Health Ethical Review
Committee), Nepal (Nepal Health Research Council Ethical
Review Board Approval), and Pakistan (National Bioethics
Committee), in addition to local hospital ethical review boards.
RESULTS

During the study period, 30 809 patients from all hospitals were recruited at outpatient clinics. The majority were male, and the median

age differed by country, as well as by catchment area within country
(Table 1). Among the 20 209 recruited at hospitals with partial adherence, 9790 (48%) were prescribed a blood culture by the treating physician; this differed by hospital (P < .001), with the lowest proportion
over the study period at Aga Khan University Hospital (40%).
At all three partial adherence hospitals, the probability of
being prescribed a blood culture varied with age (Figure 2). At
Shishu Sasthya Foundation Hospital, the probability was highest
at 5 years old, and remained relatively constant until 15 years,
but at Aga Khan University Hospital and Kharadar General
Hospital, the probability was highest between 10 and 15 years.
There was no difference in receiving a blood culture at Aga
Khan University Hospital and Kharadar General Hospital comparing males with females, but at Shishu Sasthya Foundation
Hospital, males had 10% higher odds (95% CI, 3%–19%).
Physicians’ practice for prescribing blood cultures based on
the burden of febrile illness at outpatient wards also varied by
hospital (Figure 3). At Kharadar General Hospital, the proportion of febrile outpatients prescribed a blood culture was not
significantly predicted by the number of febrile cases in the
same month (mean change per 100 cases, .14 [95% CI, −.04–
.32]). However, when compared with the number of febrile
cases in the previous 1–5 months, case counts from 3 months
prior had the strongest association, with a 31% mean increase
(95% CI, .20–.43) in the proportion prescribed a blood culture per increase in 100 febrile cases. At Aga Khan University
Hospital, the association was negative; an increase of 100 febrile cases predicted a 19% decrease (95% CI, −.24–−.15) in
the proportion prescribed a blood culture, and the association

Figure 2. Probability of receiving a prescription for blood culture, by age in years and site, (SEAP)—Partial adherence* hospitals in Bangladesh and Pakistan, April 2017–
March 2019. *Hospitals where physicians prescribed a blood culture based only on clinical suspicion and did not fully adhere to the SEAP recruitment protocol of prescribing
a blood culture to all patients with fever for 3 more days and residence within the hospital catchment area.
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To analyze clinical decision-making in regards to treatment
before and after blood culture results, we used data from consenting participants at the 3 full adherence hospitals, since patient enrollment at partial adherence hospitals was based on
clinician suspicion. We used univariate and multivariate logistic
regression to evaluate predictors of patients receiving a prescription for antibiotics before blood culture results were available.
To review the effects of antimicrobial nonsusceptibility on
treatment coverage, we analyzed the susceptibility patterns of
confirmed enteric fever cases compared with antibiotics prescribed before and after blood culture results were available at
both full and partial adherence hospitals (Figure 1). We performed this analysis using χ2 tests grouped by country, as hospitals within each country were either in the same catchment
area or within 25 km of each other.
All statistical tests were performed in R version 3.6.1 and
were considered significant at P < .05.

was weaker compared with case counts from the previous
1–5 months. At Shishu Sasthya Foundation Hospital, increases
in the number of cases in the same month or the previous
1–5 months did not predict an increase or decrease in the proportion prescribed a blood culture. We also did not observe
seasonal patterns in physicians prescribing blood culture for
febrile illness.
Among the 10 600 outpatients recruited at full adherence
hospitals, 8019 (76%) were enrolled, had blood collected, and
had available blood culture date data. Among those, 6355 (79%)
were prescribed antibiotics empirically. Patient sex did not predict receiving antibiotics empirically, but older participants had
slightly higher odds when adjusted for site (OR [age in years]
1.01, 95% CI, 1.005–1.014). Patients with female heads of the
household with postsecondary education had significantly lower
odds of receiving antibiotics empirically compared with no education, while patients who reported taking antibiotics previously and were febrile at presentation had significantly higher
odds. Patients provisionally diagnosed with fever of unknown
origin or viral fever had significantly lower odds of receiving
antibiotics empirically, while patients provisionally diagnosed
with enteric fever, lower respiratory tract infection, and urinary
tract infection had significantly higher odds. Notably, patients
provisionally diagnosed with upper respiratory tract infection
had the highest independent odds of receiving empiric antibiotics empirically among diagnoses examined (OR 5.26, 95%
CI, 2.97–10.2) (Table 2).
The choice of antibiotic class given before and after available blood culture results differed among the 3 full adherence
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hospitals (Figure 4). At Kathmandu Medical College and
Teaching Hospital, 59% of febrile outpatients received antibiotics empirically, compared with 86% at Dhaka Shishu
Hospital and 83% at Dhulikhel Hospital. Among those who received antibiotics empirically, 72% received cephalosporins at
Dhaka Shishu Hospital, while at Dhulikhel Hospital most patients received a combination of 2 or more drugs (37%) or cephalosporin monotherapy (32%). At Kathmandu Medical College
and Teaching Hospital, 34% empirically treated patients received cephalosporins, followed by macrolides (23%) and penicillin (22%). After blood culture results were available, 196/883
(22%) patients positive for any pathogen and 100/7136 (1.4%)
of patients with negative blood cultures received additional
antibiotics. At Dhaka Shishu Hospital, most blood culture positive patients with no antibiotics prescribed empirically were
switched to cephalosporin therapy. This resulted in 82% of positive patients and 63% of all patients prescribed cephalosporins
after available blood culture results. At Dhulikhel Hospital,
combinations of 2 or more drugs were the most common (51%)
treatment regimen for patients with positive blood cultures, followed by cephalosporin monotherapy (28%). At Kathmandu
Medical College and Teaching Hospital, a variety of antibiotics
were prescribed for patients with positive blood cultures, with
cephalosporins representing the most prevalent class (34%),
followed by a combination (21%).
The six hospitals and all recruitment locations had a total
of 3754 enteric fever cases. Of all enteric fever cases, 2967
(79%) received antibiotics empirically, and among those, 569
(19%) were prescribed an antibiotic that the strain they were
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Figure 3. Proportion of febrile outpatients prescribed a blood culture predicted by total number of febrile outpatients in the same month and 1–5 months ago, (SEAP)—
Partial adherence* hospitals in Bangladesh and Pakistan, April 2017–March 2019. *Hospitals where physicians only prescribed a blood culture based on clinical suspicion
and did not fully adhere to the SEAP recruitment protocol of advising a blood culture to all patients with fever for 3 or more days and residence within the hospital catchment
area.

Table 2. Independent Predictors of Febrile Patients Receiving Antibiotics Prior to Available Blood Culture Results, Surveillance for Enteric Fever in Asia
Project (SEAP) —Full Adherencee Hospitals in Bangladesh and Nepal, April 2017–March 2019
No Empiric
Antibiotics Prescribed
n = 1664 (%)

Empiric
Antibiotics Prescribed
n = 6355 (%)

Adjusted OR
(95% CI)

.989 (.986–.993)

1.01 (1.005–1.014)a

.94 (.84–1.05)

1.00 (.89–1.12)a

Ref.

Ref.

1.09 (.88–1.34)

.92 (.73–1.16)a

Demographics
Age in years, median (IQR)
Male sex

8 (3–21)
950 (57)

Education level of female head of household

n = 804

5 (2–13)
3534 (56)
n = 3271

None

166 (21)

710 (22)

Primary

275 (34)

1279 (39)

Secondary

182 (23)

678 (21)

.87 (.69–1.1)

.94 (.73–1.21)a

Postsecondary

181 (23)

604 (19)

.78 (.62–.99)

.69 (.54–.89)a

.99 (.97–1)

.99 (.96–1.01)b

1.54 (1.37–1.74)

1.55 (1.29–1.87)b

.97 (.95–.98)

1.00 (.98–1.03)b

1.75 (1.55–1.98)

1.52 (1.26–1.83)b

2.22 (1.68–2.98)

2.69 (1.73–4.35)c

3.13 (2.78–3.53)

2.01 (1.59–2.54)c

Severity
Days to seek care, median (IQR)
Previous antibiotics taken
Days unable to perform usual activities,
median (IQR)
Febrile at presentation (≥99.5°F)
Admitted

n = 1659, 3 (2–5)

n = 6344, 4 (3–5)

438/1640 (27)

2240/6221 (36)

n = 1659, 3 (.5–4)

n = 6338, 2 (0–4)

391/1662 (24)
55/1662 (3)

2223 (35)
448/6352 (7)

d

Provisional diagnosis , (row%)
Enteric fever

439 (12)

3363 (88)

LRTI

28 (5)

564 (95)

5.68 (3.95–8.53)

1.63 (1.23–2.18)c

URTI

177 (14)

1065 (86)

1.69 (1.43–2.01)

5.26 (2.97–10.2)c

Fever of unknown origin

180 (40)

269 (60)

.36 (.3–.44)

.59 (.42–.83)c

40 (12)

299 (88)

2 (1.45–2.84)

2.51 (1.41–4.8)c

286 (48)

307 (52)

.24 (.21–.29)

.22 (.17–.29)c

UTI
Viral fever
Site, (row%)
Dhaka Shishu Hospital

680 (14)

4074 (86)

Ref.

Ref.

Dhulikhel Hospital

244 (17)

1204 (83)

.82 (.7–.97)

.65 (.47–.89)c

Kathmandu Medical College and Teaching
Hospital

740 (41)

1077 (59)

.24 (.21–.27)

.24 (.18–.31)c

a

Adjusted for site.

b

Adjusted for site, demographics, and severity markers (except admission status).

c

Adjusted for site, demographics, severity markers, and other diagnoses.

d

Reference categories for diagnoses are absence of diagnosis of interest.

e

Hospitals where physicians prescribed a blood culture to all patients with fever for three of more days and residence within the hospital catchment area, based on the SEAP recruitment
protocol.

infected with tested nonsusceptible (Figure 5). This varied by
country (Bangladesh: 8%, Nepal: 11%, Pakistan: 48%, P < .001).
However, 209 (37%) of those were still covered because multiple
antibiotics were empirically prescribed. Among the 1147 (31%)
not covered by initial therapy because antibiotics had not been
empirically prescribed (n = 787), or with discordant therapy
due to nonsusceptibility (n = 360), 544 (47%) had antibiotics
added, which also varied significantly by country (Bangladesh:
48%, Nepal: 73%, Pakistan: 42%, P < .001). This ultimately resulted in a total of 20% of all enteric fever cases without antibiotic
coverage: 9% because no antibiotics were prescribed, and 11%
because the discordant therapy was not changed (Bangladesh:
8%/6%, Nepal: 7%/3%, Pakistan: 13%/23%, P < .001).
DISCUSSION

Our data revealed that clinical decision-making, both in the utilization of blood cultures for diagnosis and antimicrobial treatment of potential blood stream infections, may not be reflective

of epidemiologic and microbiologic data made available by
cultures. This is shown in the varying patterns of changes in
physicians’ clinical decision-making in ordering blood cultures
based on hospital-level burden data. Blood cultures were also
differentially utilized based on age, with the probability of receiving a blood culture not reflective of recent age-stratified
burden estimates for enteric fever in Bangladesh and Pakistan,
generated by SEAP (unpublished). Additionally, while results
from blood cultures may drive changes in patient therapy, broad
spectrum antibiotics were utilized most often, even after microbial confirmation from blood culture. Yet, antibiotics prescribed empirically did not always provide robust coverage
of bacteremic patients, especially in outbreak situations with
transmission of resistant pathogen strains.
While blood cultures remain the primary method and current standard for diagnosing bloodstream infections, this test
is utilized less in South Asian settings for suspected blood
stream infections than recommended in clinical guidelines in
Blood Culture Usage in S. Asia for Fever • cid 2020:71 (Suppl 3) • S271
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Unadjusted OR
(95% CI)

high-income countries [24]; less than half of cases with 3 days
of fever received a blood culture at hospitals with partial adherence, which may still be higher than the usual proportion
without study protocols in place.
We also found 3 different scenarios at the partial adherence
hospitals of how physicians responded to the burden of febrile disease. At Aga Khan University Hospital in Pakistan, we found that
as the number of febrile cases increased, the proportion of these
cases prescribed blood culture decreased and this association was
strongest in the same month; this would suggest that any burden
data may not be affecting diagnostic decision-making and any increase in febrile cases may be suspected to be nonbacteremic illness. At Shishu Sasthya Foundation Hospital in Bangladesh, we
found no association between increases in febrile cases and the
proportion prescribed blood culture. While viral fever outbreaks
are common [25, 26], enteric fever accounted for 63% of blood
cultures in one study in Dhaka [27], so enteric fever may be commonly suspected regardless of any changes to the burden of febrile
cases. At Kharadar General Hospital in Pakistan, the epicenter of
an XDR typhoid outbreak in Karachi, we found that febrile burden
data from 3 months prior most strongly predicted changes in the
proportion of febrile cases prescribed blood culture.

S272 • cid 2020:71 (Suppl 3) • Hemlock et al

Our study also demonstrated a wide range of clinical practice in the choice to prescribe empiric antibiotics and the antibiotic regimens chosen prior to the availability of blood culture
data. Such diversity of practice was seen even within the same
country. Empiric treatment choices were typically driven by
clinical suspicion, however recent data demonstrates that clinical diagnoses of febrile syndromes have low positive predictive value [28]. We noted that patients that reported previously
taking antibiotics were more likely to receive antibiotics empirically while patients from more educated households were less
likely, potentially reflecting healthcare-seeking behavior by education of household; another analysis of SEAP data notes that
patients from poorer households initially sought care for febrile
illness from pharmacies [22]. In this study, most febrile patients
were empirically treated with third-generation cephalosporins,
and, after blood culture and sensitivity data became available,
a further proportion were prescribed a third-generation cephalosporin or a combination of antibiotics. Initiatives to tailor
antibiotics using results from antimicrobial susceptibility patterns, rather than maintaining or broadening treatment in these
scenarios, might help improve patient outcomes [29, 30], but
are difficult considering the scope of resistance among enteric
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Figure 4. Antibiotics classes prescribed before and after results available from blood culture, by blood culture status and hospital (SEAP)—Full adherence‡ hospitals in
Bangladesh and Nepal, April 2017–March 2019. ‡ Hospitals where physicians prescribed a blood culture to all patients with fever for 3 or more days and residence within
the hospital catchment area, based on the SEAP recruitment protocol. †If no change in treatment, empiric prescription displayed. *Multiple antibiotics prescribed at given
time point.

fever, which has left few oral antibiotics available for treatment.
Disadvantages in using broad-spectrum antibiotics compared
to narrow-spectrum have been shown, such as selection for resistant bacteria and harmful effects to the microbiome, which
are especially disruptive during childhood [31].
For patient-level clinical decisions, we demonstrated that
while blood culture results can help improve the proportion
of culture-confirmed enteric fever patients with treatment

coverage, many without an effective empiric regimen are still
not prescribed an antimicrobial agent that matches culture
results, despite the available blood culture and susceptibility
testing results. There are several possible reasons why this gap
in care exists: clinicians not following up with laboratory data;
outpatients not available or not returning to hospital for their
laboratory results; physicians not changing treatment choices
due to clinical improvement; or system-wide processes that
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Figure 5. Changes to treatment after results of blood culture and antimicrobial sensitivity testing among participants with Salmonella Typhi and Paratyphi A isolated, by
country, (SEAP)—Bangladesh, Nepal and Pakistan, April 2017–March 2019. Note: This alluvial diagram depicts all enteric fever cases stratified by country and how treatment
was modified based on blood culture results. The colors originate at the first stage, where patients were categorized based on their isolate’s susceptibility pattern to antibiotics prescribed empirically, if any. Based on the antibiotic, whether multiple antibiotics were prescribed empirically, and isolate susceptibility, the second stage stratifies
patient as covered or not covered by initial therapy. The third stage depicts whether patients were prescribed additional antibiotics based on their initial therapy coverage,
resulting in the fourth stage—whether a patient’s final treatment status with the hospital resulted in coverage.

CONCLUSIONS

These data demonstrate that blood culture diagnostics have
the potential to improve the clinical management of patients
with febrile illness in South Asian settings, but reaching this
goal may require more than just performing a blood culture
test. A productive area for potential improvements in patient
care could be efforts to understand factors driving clinical decision-making, especially during outbreaks of pathogens with
antimicrobial resistance, as appropriate response to hospitallevel burden information may impact patient-care decisions.
Even though the hospitals participating in the study had strong
laboratory capacity, the processes to inform treating physicians
were less operationalized in all of these settings. Optimizing
communication strategies, as well as developing a systems
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approach to facilitate better coordination, could also contribute
to this. As seen with our data, blood culture and antimicrobial
susceptibility testing can help to ensure those with bacteremia
are treated with an appropriate antimicrobial regimen in a
timely manner. Future efforts to establish a low-cost, rapid test
with high sensitivity and specificity are needed to contribute
to the appropriate narrowing of the antimicrobial spectrum.
Considering the increasing antimicrobial resistance in these
settings, blood culture should be utilized more effectively in the
present to guide clinical practice, especially where laboratory
capacity is already established.
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